Public Health England warns that improved treatment and testing rates for STIs in the UK could be imperilled by cuts
Benefits of dolutegravir treatment for all substantially outweigh the risks
Managing sexual and survival risks: the impact of inequity and stigma on Jamaican MSM and trans women
Women with HIV have increased risk of missed menstrual periods
Stigma, access and testing: why HIV is still rising in Europe
